CYFIP2 Antibody
Disease:Up-regulated significantly in CD4+ T lymphocytes from patients with multiple sclerosis (at protein level) . Involved in T-cell adhesion and p53-dependent induction of apoptosis. Does not bind RNA. induction:By p53. RNA editing:Partially edited. Editing appears to be brain-specific. Belongs to the CYFIP family. subcellular location:Highly expressed in the perinuclear region. Enriched in synaptosomes. Treatment with leptomycin-B triggers translocation to the nucleus. subunit:Interacts with FMR1, FXR1 AND FXR2. Component of the WAVE1 complex composed of ABI2, CYFIP2, C3orf10/HSPC300, NCKAP1 and WASF1/WAVE1. CYFIP2 binds to activated RAC1 which causes the complex to dissociate, releasing activated WASF1. The complex can also be activated by NCK1.
Product Specifications
Immunogen
Synthesized peptide derived from CYFIP2 at AA range: 1171-1220
Antibody Type
Primary Antibodies
Product Name Synonym
Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121) antibody
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog